Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. PV-10 (10% rose bengal disodium)

   PROVECTUS BIOPHARMACEUTICALS, INC.

   Melanoma

   phase 2 · small molecule · completed

   1 trial →

2. PYX-201

   Pyxis Oncology

   Advanced Solid Tumors

   phase 2 · small molecule · active

   1 trial →

3. PYX-201-102

   Pyxis Oncology

   Advanced Solid Tumors

   phase 2 · other · active

   1 trial →

4. Paclitaxel

   Merck KGaA, Darmstadt, Germany

   Esophageal Squamous Cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

5. Paclitaxel

   CNS Pharmaceuticals

   Ovarian Cancer

   phase 2 · small molecule · completed

   1 trial →

6. Paclitaxel

   ONCOLYTICS BIOTECH INC

   Metastatic Breast Cancer

   phase 2 · small molecule · completed

   1 trial →

7. Paclitaxel

   ONCOLYTICS BIOTECH INC

   Breast Cancer Metastatic

   phase 2 · small molecule · active

   1 trial →

8. Paclitaxel

   PUMA BIOTECHNOLOGY, INC.

   Breast Cancer

   phase 2 · small molecule · completed

   1 trial →

9. Paclitaxel

   United Therapeutics Europe Ltd

   Clinical Stage III Gastric Cancer AJCC v8

   phase 2 · small molecule · active

   1 trial →

10. Paclitaxel

    Takeda

    Ovarian Cancer

    phase 2 · small molecule · completed

    1 trial →

11. Paclitaxel

    Takeda

    Endometrial Neoplasms

    phase 2 · small molecule · completed

    1 trial →

12. Paclitaxel

    Jazz Pharmaceuticals Ireland Limited

    Gastroesophageal Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

13. Paclitaxel

    Cardiff Oncology

    Carcinosarcoma

    phase 2 · small molecule · active

    1 trial →

14. Paclitaxel /ml Concentrate for Resectable Locally Advanced Ora…

    Fondazione Telethon ETS

    Resectable Locally Advanced Oral Cavity Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

15. Paclitaxel and TAK-228

    Takeda

    Metastatic Urothelial Cancer

    phase 2 · other · active

    1 trial →

16. Palbociclib 125Mg Tab

    United Therapeutics Europe Ltd

    ER+ Breast Cancer

    phase 2 · small molecule · active

    1 trial →

17. Palifosfamide Tris and Doxorubicin

    Alaunos Therapeutics

    Soft Tissue Sarcoma

    phase 2 · small molecule · active

    1 trial →

18. Pancreatoduodenectomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Cancer

    phase 2 · other · active

    1 trial →

19. Panitumumab

    Takeda

    Squamous Cell Carcinoma of Head and Neck

    phase 2 · small molecule · completed

    1 trial →

20. Panitumumab

    United Therapeutics Europe Ltd

    Metastatic Colon Adenocarcinoma

    phase 2 · mab · active

    1 trial →

21. Panitumumab

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Head and Neck Squamous Cancer

    phase 2 · small molecule · completed

    1 trial →

22. Panitumumab + TAS-102

    Takeda

    Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

23. Panitumumab-2003

    Takeda

    Colorectal Carcinoma

    phase 2 · small molecule · completed

    1 trial →

24. Panobinostat

    Zealand Pharma A/S

    Rhabdoid Tumor

    phase 2 · small molecule · terminated

    1 trial →

25. Panobinostat

    Novartis Pharmaceuticals

    Classical Hodgkin's Lymphoma

    phase 2 · small molecule · completed

    1 trial →

26. Pantoprazole 40mg

    Zealand Pharma A/S

    Oncology

    phase 2 · small molecule · completed

    1 trial →

27. Panzem Nanocrystal Colloidal Dispersion (NCD)

    CASI Pharmaceuticals

    Ovarian Cancer

    phase 2 · small molecule · completed

    1 trial →

28. Panzem® NCD

    CASI Pharmaceuticals

    Metastatic Renal Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

29. Panzem® NCD

    CASI Pharmaceuticals

    Prostate Cancer

    phase 2 · small molecule · completed

    1 trial →

30. Parsaclisib

    Incyte

    Lymphoma

    phase 2 · small molecule · completed

    1 trial →

31. Part 1: VP-315 3 Day Dosing/Week

    Verrica Pharmaceuticals

    Basal Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

32. Patritumab deruxtecan

    Daiichi Sankyo

    Locally Advanced or Metastatic Solid Tumors

    phase 2 · small molecule · active

    1 trial →

33. Patritumab deruxtecan

    Daiichi Sankyo

    Metastatic or Locally Advanced EGFR mutated Non-Small Cell Lung Cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

34. Patupilone

    Novartis Pharmaceuticals

    Hepatocellular Carcinoma

    phase 2 · small molecule · completed

    1 trial →

35. Paxalisib

    KAZIA THERAPEUTICS LTD

    Childhood Cancer

    phase 2 · small molecule · active

    1 trial →

36. Pedmark® STS

    FENNEC PHARMACEUTICALS INC.

    Solid Tumor Malignancies

    phase 2 · small molecule · active

    1 trial →

37. Pegvorhyaluronidase alfa

    HALOZYME THERAPEUTICS, INC.

    Pancreatic Ductal Adenocarcinoma

    phase 2 · small molecule · terminated

    1 trial →

38. Pegylated Irinotecan

    Nektar Therapeutics UK Limited

    Recurrent Small Cell Lung Carcinoma

    phase 2 · small molecule · completed

    1 trial →

39. Pegylated Irinotecan

    Nektar Therapeutics UK Limited

    Stage IV Non-small Cell Lung Cancer (NSCLC)

    phase 2 · small molecule · completed

    1 trial →

40. Pelareorep

    ONCOLYTICS BIOTECH INC

    Anatomic Stage IV Breast Cancer AJCC v8

    phase 2 · mab · active

    1 trial →

41. Pelareorep

    ONCOLYTICS BIOTECH INC

    Anal Cancer Metastatic

    phase 2 · small molecule · active

    1 trial →

42. Pemazyre 4.5 mg tablets

    Ningbo Cancer Hospital

    Recurrent or metastatic solid cancer harboring a FGFR1,2 ,3 fusion/rearrangement or activating mutation, outside of the approved indications for any selective FGFR inhibitor in France

    phase 2 · small molecule · active

    1 trial →

43. Pemazyre 4.5 mg tablets

    The George Institute

    locally advanced intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements

    phase 2 · small molecule · active

    1 trial →

44. Pembrolizumab

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

45. Pembrolizumab

    Bicara Therapeutics

    Head and Neck Squamous Cell Carcinoma

    phase 2 · mab · active

    1 trial →

46. Pembrolizumab

    IO Biotech

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

47. Pembrolizumab

    Inhibrx Biosciences

    Triple Negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

48. Pembrolizumab

    Syndax Pharmaceuticals

    Metastatic Uveal Melanoma

    phase 2 · small molecule · completed

    1 trial →

Frequently asked questions